|
PPP4R1 expression based on
|
KIRC : Kidney renal clear cell carcinoma
| Comparison | Statistical significance |
| Normal-vs-Primary | 1.365820E-04 |
|
KIRC : Kidney renal clear cell carcinoma Note
Cancer stage information is not available for 2 samples.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Stage1 |
1.166230E-02 |
| Normal-vs-Stage2 |
5.047100E-04 |
| Normal-vs-Stage3 |
2.03699999999918E-05 |
| Normal-vs-Stage4 |
3.360800E-04 |
| Stage1-vs-Stage2 |
7.403800E-02 |
| Stage1-vs-Stage3 |
7.938900E-03 |
| Stage1-vs-Stage4 |
6.729900E-02 |
| Stage2-vs-Stage3 |
8.345200E-01 |
| Stage2-vs-Stage4 |
8.406200E-01 |
| Stage3-vs-Stage4 |
6.430800E-01 |
|
|
KIRC : Kidney renal clear cell carcinoma Note
Patient race information is not available for 7 samples.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Caucasian |
2.21699999999325E-05 |
| Normal-vs-AfricanAmerican |
2.250600E-01 |
| Normal-vs-Asian |
7.589600E-01 |
| Caucasian-vs-AfricanAmerican |
1.227790E-01 |
| Caucasian-vs-Asian |
2.413600E-01 |
| AfricanAmerican-vs-Asian |
7.910200E-01 |
|
|
KIRC : Kidney renal clear cell carcinoma
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Male |
5.87459999999984E-05 |
| Normal-vs-Female |
4.043100E-03 |
| Male-vs-Female |
2.568000E-01 |
|
|
KIRC : Kidney renal clear cell carcinoma
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Age(21-40Yrs) |
2.390200E-01 |
| Normal-vs-Age(41-60Yrs) |
3.995700E-03 |
| Normal-vs-Age(61-80Yrs) |
2.05729999999127E-05 |
| Normal-vs-Age(81-100Yrs) |
1.103870E-02 |
| Age(21-40Yrs)-vs-Age(41-60Yrs) |
5.875600E-01 |
| Age(21-40Yrs)-vs-Age(61-80Yrs) |
1.481960E-01 |
| Age(21-40Yrs)-vs-Age(81-100Yrs) |
2.151600E-01 |
| Age(41-60Yrs)-vs-Age(61-80Yrs) |
4.512300E-02 |
| Age(41-60Yrs)-vs-Age(81-100Yrs) |
2.369000E-01 |
| Age(61-80Yrs)-vs-Age(81-100Yrs) |
7.094600E-01 |
|
|
KIRC : Kidney renal clear cell carcinoma Note
Tumor grade information is not available for 3 samples and undetermined for 5 samples.
| Subtype descriptions |
| Grade 1 | Well differentiated (low grade) |
Grade 2 | Moderately differentiated (intermediate grade) |
| Grade 3 | Poorly differentiated (high grade) |
Grade 4 | Undifferentiated (high grade) |
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Grade 1 |
7.217800E-01 |
| Normal-vs-Grade 2 |
5.520300E-02 |
| Normal-vs-Grade 3 |
1.77815999999886E-05 |
| Normal-vs-Grade 4 |
3.41059999997562E-06 |
| Grade 1-vs-Grade 2 |
5.610400E-01 |
| Grade 1-vs-Grade 3 |
3.111900E-02 |
| Grade 1-vs-Grade 4 |
1.692380E-02 |
| Grade 2-vs-Grade 3 |
2.168600E-04 |
| Grade 2-vs-Grade 4 |
6.577700E-04 |
| Grade 3-vs-Grade 4 |
2.863200E-01 |
|
|
KIRC : Kidney renal clear cell carcinoma NOTE
Subtype information is not available for 153 samples.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-ccA subtype |
2.264100E-03 |
| Normal-vs-ccB subtype |
1.541590E-03 |
| ccA subtype-vs-ccB subtype |
6.161200E-01 |
|
KIRC subtypes: Brooks SA et al, ClearCode34: A prognostic risk predictor for localized clear cell renal cell carcinoma. Eur Urol. 2014 Jul;66(1):77-84. doi: 10.1016/j.eururo.2014.02.035
|
KIRC : Kidney renal clear cell carcinoma Note
Cancer in nearby lymph nodes cannot be measured (NX) in 277 samples.
| pathologic_N descriptions |
| N0 | No regional lymph node metastasis |
N1 | Metastases in 1 to 3 axillary lymph nodes |
| N2 | Metastases in 4 to 9 axillary lymph nodes |
N3 | Metastases in 10 or more axillary lymph nodes |
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-N0 |
1.562450E-04 |
| Normal-vs-N1 |
7.270100E-02 |
| N0-vs-N1 |
9.698000E-01 |
|
|
